HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.

AuthorsE Sprecher, R Bergman, R Friedman-Birnbaum
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 12 Issue 2 Pg. 197-8 (Mar 1999) ISSN: 0926-9959 [Print] England
PMID10343966 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Keratolytic Agents
  • Vancomycin
  • Cyclosporine
  • Cefazolin
  • Acitretin
Topics
  • Acitretin (therapeutic use)
  • Anti-Bacterial Agents (therapeutic use)
  • Cefazolin (therapeutic use)
  • Cephalosporins (therapeutic use)
  • Cyclosporine (therapeutic use)
  • Dermatitis, Exfoliative (complications, drug therapy)
  • Dermatologic Agents (therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Keratolytic Agents (therapeutic use)
  • Male
  • Middle Aged
  • Psoriasis (complications, drug therapy)
  • Sepsis (microbiology)
  • Staphylococcal Infections (complications, drug therapy)
  • Streptococcal Infections (complications, drug therapy)
  • Vancomycin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: